featured
Junction Plakoglobin Regulates and Destabilizes HIF2α to Inhibit Tumorigenesis of RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer communications (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Junction Plakoglobin Regulates and Destabilizes HIF2α to Inhibit Tumorigenesis of Renal Cell Carcinoma
Cancer Commun (Lond) 2021 Feb 16;[EPub Ahead of Print], K Chen, J Zeng, Y Sun, W Ouyang, G Yu, H Zhou, Y Zhang, W Yao, W Xiao, J Hu, J Xing, K Xiao, L Wu, Z Chen, Z Ye, H XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.